Unknown

Dataset Information

Salient Cognitive Paradigms to Assess Preclinical Alzheimer's Disease.


ABSTRACT: Despite the growing emphasis to identify early biological markers that can detect the progressive accumulation of brain pathology in the complex pathophysiologic cascade that occurs in Alzheimer's disease (AD), we continue to employ the same neuropsychological paradigms that were developed to detect dementia or frank cognitive impairment. It has become increasingly clear that we cannot expect to measure clinically meaningful change in relationship to these emerging preclinical biomarkers using these traditional cognitive assessment paradigms, nor will we advance the efforts to identify the earliest cognitive changes that emerge in AD. Over the last decade, a few novel promising cognitive assessment paradigms have emerged that have shown promise in identifying subtle cognitive deficits in A

SUBMITTER: Cid REC 

PROVIDER: S-EPMC9130422 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature